Register for LEARNMD Name(Required) First Last Email(Required) Position(Required) Clinician Researcher Allied Health Student NMD4C Staff MDC Staff Specialization(Required)Select SpecializationNeurologistPhysiatristCardiologistRespirologistEndocrinologistGastroenterologistOrthopedic specialistGeneral practitionerGeneticistPediatricianPathologistNeuropathologistNeurophysiologistPsychologist/neuropsychologistResident (neurology)Resident (physiatry)Resident (other)Clinical fellow (neuromuscular)Clinical fellow (other)Speech-language pathologistPostdoctoral fellowResearch TechnicianResearch AssistantResearch AssociateAssistant ProfessorAssociate ProfessorAdjunct Professor*ProfessorResearch coordinatorScientific directorSenior scientistsClinical investigatorResearch managerPhysiotherapistOccupational therapistNurseSocial workerRespiratory therapistDietician/NutritionistGenetic counsellorCare coordinatorClinical coordinator/assistantRegistered massage therapistSpeech therapistUndergraduate studentMSc studentPhD studentMedical studentOtherOther Specialization(Required)Level of Expertise(Required) Beginner Intermediate Expert Pediatrics or Adult Medicine(Required) Pediatrics Adult Research interests(Required)3D models5q SMA6 minute walk test (6MWT)Aautoimmune myopathiesAboriginalAccessibilityAcetazolamideAcetylcholine receptors (AChR)Acid alpha- glucosidase (GAA)Acid maltase deficiencyactininopathy (ACTN2)activities of daily living (ADLs)Acute Inflammatory Demyelinating Polyneuropathy (AIDP)Acute motor axonal neuropathy (AMAN)Acute motor sensory axonal neuropathy (AMSAN)Acute polyradiculoneuropathyAdaptive aidsAdeno-associated virus (AAV)Adenosine deaminase (ADA) deficiencyAdenosine triphosphate (ATP)Adult careAdultsAdvanced therapies medical products (ATMPs)AdvocacyAerobic exerciseAgamreeAgamreeAgoraphobiaAlcoholismAlglucosidase alfaAlpha dystroglycanopathiesAlternative diagnosisAmbulatory stageAmerican College of Medical Genetics and Genomics (ACMG)AmniocentesisAMP-activated protein kinase (AMPK)Amyotrophic Lateral Sclerosis (ALS)AnalgesiaAndrogen receptor geneAnesthesiaAnesthetic complicationsAnimal modelsAnkle foot ortothics (AFOs)Anoctomin 5 (ANO5)AntibodiesAntibody testingAnti-jo1AntioxidantsAntisense oligonucleotides (ASOs)Antisynthetase syndrome (ASS)AnxietyAquatherapyAquatic therapyArediaArsenicArthrogryposis multiplex congenita (AMC)AspirationsAssessmentsAssistive devicesAssistive technologyAstagraf XLAtaxiaATPase 6 geneAtulurenAugmentative and alternative communication (AAC)AutoimmuneAutoimmune diseasesAutophagic vacuolar myopathiesAutosomal dominant inheritanceAutosomal recessive inheritanceAxonal peripheral neuropathiesAxonsAzathioprineBalanceBarth syndrome (BTHS)Basal laminaBatoclimabB-cell depletionBecker muscular dystrophy (BMD)Becker myotonia congenita (BMC)Bethlem myopathyBiobanksBiologicsBiologyBiomarkersBiopsyBiPAPBisphosphenatesBody mass index (BMI)BonesBotulismBrachial plexusBreastfeedingBreathingBrown-Vialetto-Van Laere (BVVL)Bulbar functionBurghes modelC.elegansCalcortCalpain-3 (CAPN3)CalpainopathiesCalpainopathyCanadian Agency for Frugs and Technologies in Health (CADTH)Canadian Neuromuscular Disease Registry (CNDR)CancerCardiac systemCare considerationsCare guidelinesCaregiversCaregivingCarm1CarriersCas9Case examplesCasein Kinase 1a (CK1a)CasimersenCatenaCavusCell divisionCell therapyCellCeptCellsCentral core diseaseCentral nervous system (CNS)Central neuropathyCentronuclear myopathyCentronucleiCervical myelopathyChacot-Marie-Tooth (CMT) diseaseChannelopathiesChaperone therapyChemogeneticsChemotherpay induced neuropathyChest infectionsChest wallChewingChimeric antigen receptor (CAR)Chloride channelChokingChondrodystrophic myotoniaChorionic villus sampling (CVS)Chromosomal microarrayChromosomesChronic inflammatory demyelinating polyneuropathy (CIDP)CK0801ClassificationsCLCN1ClenbuterolClinical courseClinical criteriaClinical manifestationClinical presentationClinical researchClinical trialsCoenzyme Q10CognitionCognitive behavioural therapy (CBT)Cognitive impairementCohort studyCOL 6COL VICOL6AColchicineCollagen VICombinatorial therapiesCombined drug treatmentCommon drug review (CDR)Community care supportsCompartment syndromeComplement inhibitionComplex IV deficiencyComplex V deficiencyComponents of careCongenitalCongenital fibre type disproportionCongenital muscular dystrophyCongenital myasthenia gravis (CMG)Congenital myasthenic syndrome (CMS)congenital myopathiesCongenital myopathyCongenital myotonic dystrophycongential muscular dystrophyContracturesCopingCOQ7Core myopathiesCorticosteroidsCough assist machinesCounsellingCOVID-19CrampsCreatineCreatine kinase (CK)Creatine monohydrateCreatine phosphokinase (CPK)CRISPRCross-reactive immunologic material (CRIM) statusCyclophosphamideCyclosporineCytogenetic nomenclatureCytokinesDanon diseaseDe novo mutationsDecision aidsDecision coachingDecision supportDeficienciesDeflazacortDelandistrogene moxeparvovec-roklDelayed diagnosisDelphi methodDemyelinatingDenosumabDermatomyositisDesigner Receptors Activated Only by Designer Drugs (DREADDs)DesminopathyDiabetesDiagnosisDiagnostic evaluationDiagnostic odysseyDiagnostic techniquesDiagnosticsDiamoxDicarboxylic aciduriaDietDifferential diagnosisDigestive systemDilated cardiomyopathyDisability and health framework (ICF)Disability modelDisability rightsDisease progressionDisequilibriumDisseminationDistal ABD-filaminopathyDistal actininopathyDistal Hereditary Motor NeuropathiesDistal myopathiesDistal myopathyDMPK geneDok7Double homeobox 4 (DUX4) geneDrug approval processDrug developmentDry blood spot (DBS)Duchenne muscular dystrophy (DMD)DysarthriaDysferlinDysferlinopathiesDysphagiaDystroglycanDystrophiesDystrophinDystrophinopathiesEarly diagnosisEarly onsetEculizumabEDO51EfgartigimodElectromyography (EMG)ElectrophysiologyElevidysEmbryosEmery-Dreifuss muscular dystrrophyEmflazaEmotional supportEndocrine systemEnergy cycleEnhanced first trimester screening (eFTS)EntyvioEnvarsus XREnzyme replacement therapy (ERT)EnzymologyEosinophilsEpidemiologyEpigeneticsEpilepsyEpileptic disodersEquilibriumEteplirsenEthicsEuropean Medicines Agency (EMA)EvrysdiEx vivoExcessive daytime sleepiness (EDS)ExerciseExome sequencingExon skippingEx-PLISSIT modelExternal opthalmoplegiaEyelidsFacioscapulohumeral muscular dystrophy (FSHD)Fall preventionFAM83HFamiliar cerebellar ataxiaFamiliesFamily historyFamily planningFat embolism syndromeFat metabolismFatigueFatty acid oxidation defects (FAODs)Fatty acidsFazio-Londe (FL) syndromeFc receptor inhibitorFcRnFeeding tubesFeetFiberoptic endoscopic evaluation (FEES)FibrosisFibular neuropathyFirdapseFKRPFloppy babyFluorescence in situ hybridization (FISH)Focal corticol dysplasiaFocal refractory epilepsyFood and Drug Administration (FDA)Forbes-Cori diseaseForced vital capacity (FVC)Founder effectFracturesFriedreich ataxia (FA)Fukuyama congenital muscular dystrophy (FCMD)Functional gaitFunctional measuresFunctional motor scalesGamma-aminobutyric acid (GABA)GapmersGastric tubesGastrointestinal (GI) problemsGastrointestinal (GI) systemGene additionGene correctionGene editingGene panelGene panelGene replacement therapy (GRT)Gene silencingGene silencing agentsGene therapyGene transferGeneralized Achr antibody positiveGeneralized hypertrophyGeneralized myasthenia gravis (gMG)GenesGenetic counsellingGenetic counsellorGenetic modelsGenetic neuromuscular disordersGenetic neuropathiesgenetic neuropathyGenetic testingGenetic therapiesGenetic variantsGeneticsGengrafGenome editingGenomic variantsGenomicsGJB1GlucocorticoidsGlucoseGlutamateGlutamate-gated chloride (GluCl)GlycogenGlycogen storage disease (GSD)Glycogen storage disorder type 2 (GSD II/GSD 2)Glycogen synthase kinas -3 (GSK-3) inhibitorGNE myopathyGoal directed therapyGolodirsenGower's maneuverGranzymesGriefGross motor skillsGuidelinesGuillain-Barré syndrome (GBS)HaplotypesHead controlHealth CanadaHealth technology assessmentHearingHereditary motor neuron diseaseHereditary peripheral neuropathiesHereditary sensory motor neuropathiesHereditary spastic paraplegia (HSP)HeterogeneityHip dysplasiaHistologyHistopathologyHome modificationsHome supportHome ventilationHopkins Falls Grading ScalehydrotherapyHyperCKemiaHyper-eosinophiliaHyperkalemic periodic paralysisHypotoniaHypoxemiaIdebenoneIdefirixIgG1IgG3ImagingImlifidaseImmune modulatorsImmune systemImmune-mediated myopathiesImmune-mediated necrotizing myopathyImmunomodulationImmunoreactionImmunosuppressantsImmunotherapiesImuranIn vivoInclusion body myopathyInclusion body myositis (IBM)Inclusivity/diversity/equity/accessibility (IDEA)IndigenousInduced pluripotent stem cells (iPSC)InfancyInfantInfantile onset Pompe disease (IOPD)InfectionsInflammationInflammatory muscle diseaseInflammatory myopathiesInflammatory neuromuscular disordersInformation seekingInguinal nervesInheritanceInheritance patternInotersenInstitut national d'excellence en sante et en services sociaux (INESS)Integrated knowledge translationInterdisciplinary careIntergenomic signallingInternational association for public participation (IAP2)International classification of function (ICF)International Classification of Functioning Disability and HealthInterventionsIntravenous (IV)Intravenous immunoglobulin (IVIG)In-vitro fertilization (IVF)IV immunoglobulinsJourney mapJubbontiJuvenile dermatomyositisJuvenile onset sporadic distal myopathyJuvenile recessive distal titinopathiesKaryotypeKearns-Sayre syndromeKennedy's diseaseKnowledge implementationKnowledge mobilizationKnowledge synthesisKnowledge to action (KTA) cycleknowledge translation (KT)Laing distal myosinopathyLAMA2-associated muscular dystrophiesLambert-eaton myasthenic syndrome (LEMS)LamininLaryngospasmLate onsetLate onset Pompe disease (LOPD)LeukodystrophiesLimb-girdle muscular dystrophy (LGMD)Lipid metabolismLissencephalyLived experiencesLiver diseaseLiver dysfunctionLosmapimodLower limb neuropathiesLower motor neuron diseaseL-tyrosineLumbosacral plexopathiesLumbosacral plexusLumizymeLung functionLysosomal diseaseMagnetic resonance imaging (MRI)Malignant hyperthermiaManagementMAP3K7MAPKMaternally inherited Leigh's syndrome (MILS)McArdle diseaseMDC1Amechanical ventilationMechanismsmediatedMental healthMerosinMerosinopathiesMessenger RNA (mRNA)MestinonMetabolic myopathiesmetabolic neuropathiesMetabolic systemMetabolismMethotrexateMFN2microcephalyMicrodystrophinMiller Fisher Syndrome (MFS)MimicsMinicore myopathyMisdiagnosisMitchondrial myopathiesMitochondriaMitochondrial diseaseMitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS)Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)Mitochondrial protein synthesisMitogen-activated protein kinase kinase kinase 7Mobile health (mhealth)MobilityMonogenic disordersMotor functionMotor nerve conduction studyMotor neuron diseaseMotor neuronsMotor skillsMouse modelsMPZMultidisciplinary careMultifocal Motor Neuropathy (MMN)Multiminicore myopathyMultisystem proteinopathyMultisystemic diseaseMuRF myopathyMuscle CoQ10 deficiencyMuscle damageMuscle fibersMuscle metabolismMuscle myotoniaMuscle pathologyMuscle stem cellsMuscle toneMuscle weaknessMuscular dystrophyMuscular systemMusculoskeletal systemMuSKMutationsMyalgiaMyasthenia gravis (MG)Mycophenalate mofetilMyelin sheathMyelinated fibersMyelinopathiesMyelinopathyMyoclonic epilepsy with ragged red fibers (MERRF)Myocopgenolate mofetilMyofiberMyofibrillar myopathiesMyogenesisMyoglobinuriaMyokinesMyopathiesmyopathologyMyophosphorylase deficiencyMyoshi myopathyMyosin storage myopathyMyositisMyotilinopathyMyotoniaMyotonia congenitaMyotonic dystrophyMyotonic dystrophy protein kinase gene (DMPK gene)Myotonic dystrophy type 1 (DM1)Myotonic dystrophy type 2 (DM2)Myotonic muscular dystrophyMyotubesMyotubular myopathyMyozymeNebulinNecrotizing autoimmune myopathyNemaline myopathyNeoralNerve conduction studies (NCS)Nerve conduction studyNeuroacanthocytosis disordersNeurobehavioursNeurodegenerationNeurodevelopmentalNeurofilamentsNeuromuscular junction (NMJ)Neuromuscular myopathiesNeuromuscular pathologyNeuromuscular systemNeuromuscular transmission disordersNeuropathic painNeuropathiesNeuropathologyNeuropathyNeurophysiologyNewborn screening (NBS)Next generation ERT (NG-ERT)Next generation sequencing (NGS)NilotinibNipocalimabNon dystrophic myopathiesNon dystrophy myotonic syndromesNon invasive ventilation (NIV)Nonaka myopathyNonalcoholic fatty acid diseaseNondystrophic myotoniaNonelectric pseudomyotoniaNon-invasive prenatal screening (NIPS)Nuclear gene defectsNursesNusinersenNutrientsNutritionOccupational therapy (OT)Ocular myasthenia gravis (MG)Oculopharyngeal muscular dystrophy (OPMD)Onasemnogene abeparvovecOPA1Orthopedic managementOrthopedicsOrthosesOrthoticsOsteokinesOsteoporosisOtrexupOutcome measuresOverlap myositisPABPN1 genePaget disease of bone (PDB)Paget diseasePainPamidronatesPanel testingParacrine signalingParamyotonia congenitaparentParentingPartial pressure of carbon dioxide (PaCO2)Pathogenesispathogenic variantPathologyPathologyPathomechanismsPathophysiologyPatient carePatient engagementPatient oriented research (POR)Patient registryPatient reported outcome measures (PROMs)Patient-partnersPatientsPeak cough flowPearson syndromePediatric carePediatricsPeripheral nervePeripheral nervous system (PNS)Peripheral neuropathiesPeripheral neuropathyPGN-EDODM1Pharmacological chaperone therapyPharyngeal hypersecretionsPhenotypesPhosphofructokinase (PFK) deficiencyPhysical activityPhysical therapistsPhysical therapyPhysiologyPhysiotherapistPhysiotherapy (PT)PlaceboPlasma exchange (PLEX)PlasmapheresisPLIN4 myopathyPMP22PneumoniaPneumothoraxPoisonsPolioPolio-like syndromesPoliomyelitisPolymerase gamma (POLG)PolymyositisPolysomnographyPompe DiseasePostpartumPost-poliomyelitis syndromePostsynapticpostsynaptic neuromuscular junction disordersPosturePotassium-aggravated myotoniaPRC-SaltilloPrednisolonePrednisonePrednisone IntensolPregnancyPre-implantation genetic testing for monogenic condition (PGT-M)Prenatal screeningPresynapticpresynaptic neuromuscular junction disordersPrior protein systemic amyloidosisPrognosisPrografProgressionProgressive external opthalmoplegia (PEO)ProliaProtein aggregate myopathiesProtein synthesisProximalPsychologistsPsychosocialPtosisPubertyPulmonary systemPyridostigminePyridoxineQalsodyQualitative methodsQuality of life (QOL)Quantitative methodsRadiationRandomized control trial (RCT)Range of motionRANKLRasuvoRavalizumabRaxoneRayosReceptor activator of nuclear factor kappa beta (NFkB ligand)Reducing body myopathyRefractory myasthenia gravis (MG)RegenerationRegistryRegulatory processRehabilitationRepeat analysisresearchRespirationRespiratory managementRespiratory systemRespiratory therapistRestless leg syndromeRetinitis pigmentosa syndrome (NARP)Retrospective chart reviewRhabdomyolysisRheumatrexRiboflavinRiboflavin transporter deficiency (RTD)Rigid spine muscular dystrophy (RSMD)Rimmed vacuolesRisdiplamRituxanRituximabRNA sequencingRNA splicingRod myopathyRozanolixizumabRyanodine receptor 1 (RyR1)RYR1 myopathyRYR1-mutated calk myopathyRystiggoSaguenay-Lac Saint-JeanSalbutamolSarcoglycanopathiesSarcoglycanopathySarcolemmaSatellite cellsScapular wingingSchoolSchwartz-Jampel syndromeSciatic neuropathySCN4A mutationScoliosisScoliosisScreeningSecondary motor neuron diseaseSeizuresSelf-esteemSenescent cellsSensory nerve conduction studySensory neuropathiesSensory systemSEPN1SEPN1-related myopathySequential treatmentSequestosome 1SeronegativeSevere Combined Immunodeficiency (SCID)Severe neonatal episodic laryngospasm (SNEL)SeveritySexSexual healthsexualityShared decision makingSignal intensitySingle cell genomicsSingle gene sequencingSkeletal musclesSleepSleep disordered breathingSleep studySMN 2 geneSMN proteinSocial workersSodium channelSolarisSolirisSovrimaSpastic paraplegia type 50Special access program (SAP)SpeechSpeech language pathologist (SLP)Speech therapySpinal bulbar muscular atrophy (SBMA)Spinal deformitiesSpinal muscular atrophy (SMA)Spinobulbar muscular atrophy (SBMA)SpinrazaSpirometrySpiropentSporadic inclusion body myopathySporadic inclusion body myositis (IBM)Sporadic motor neuron diseaseSQSTM1SRP-9001SserologyStandards of careStatinsSteinert diseaseStem cellsSteroidsStrategy for patient oriented research (SPOR)StressSubacute combined degenerationSubstrate reduction therapy (SRT)SubtypesSupplementsSupportsSurgeriesSurgerySurvival Moton Neuron (SMN)SwallowSymptomsSyntrophinSystem navigationT cellsTacrolimusTAK1TamoxifenTarsal tunnel syndromeTarui's diseaseTasignaTCPS2TechnologyTegesediTelehealthTestingTGFB pathwayThalliumThe Neuromuscular Disease Network for Canada (NMD4C)TherapeuticsTherapiesTherapyThiamineThird generation sequencingThomsen myotonia congenita (TMC)Tibial muscular dystrophyTibial neuropathyTideglusibTissue homeostasisTitin (TTN)TitinopathiesTitinopathyTNNT1 myopathyTobii DynavoxTofersenToxix neuropathiesTracheostomyTranscriptome sequencingTransforming growth factor beta (TGFB) signaling pathwayTransition of careTranslarnaTranslational researchTraumasTreatmentsTrehaTrehaloseTrexallTrisomy 13Trisomy 18Trisomy 21Troponin T1TumorsUllrich Congenital Muscular Dystrophy (UCMD)Ultrasound (US)Unfolded protein response (UPR)Upper limb neuropathyUpper motor neuron diseaseUremic neuropathyUrinary glucose tetrasaccharide (Hex4)VaccinesVacuolar myopathiesVamoroloneVariants of unknown significance (VUS)VasculitisVCP-myopathyVentilatorsVertigoVestibular healthViral gene therapyViral vectorsVirtual carevirtual careVitaminsVyvgartWalker Warburg Syndrome (WWS)WDR5 proteinWelander distal myopathywheelchairsWhole exome sequencingWhole genome sequencingWorld Health Organization (WHO)WyostXgevaX-linkedX-linked cardiomyopathyYogaZaspopathyZebrafishZilucoplanZoledronic acidZolgensmaZometaType of Science(Required) Translational Clinical Both CommentsThis field is for validation purposes and should be left unchanged.
